BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 21348415)

  • 1. The development of anti-HIV-1 drugs.
    Lu XF; Chen ZW
    Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
    Zheng PR; Xue H; Xiao ZY; Liu G
    Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs for old.
    Winston A; Stebbing J
    J HIV Ther; 2005 Mar; 10(1):11-6. PubMed ID: 15951729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiretroviral drugs.
    Hanson K; Hicks C
    Curr HIV/AIDS Rep; 2006 Jul; 3(2):93-101. PubMed ID: 16608666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antiretroviral drugs.
    Gulick RM
    Clin Microbiol Infect; 2003 Mar; 9(3):186-93. PubMed ID: 12667250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 antiretroviral drug therapy.
    Arts EJ; Hazuda DJ
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a007161. PubMed ID: 22474613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists.
    Hughes A; Barber T; Nelson M
    J Infect; 2008 Jul; 57(1):1-10. PubMed ID: 18556070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The newest developments in anti-HIV-1 drugs].
    Zhang XQ
    Yao Xue Xue Bao; 2010 Feb; 45(2):194-204. PubMed ID: 21351429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of antiretroviral therapy.
    Di Perri G; Sinicco A; Audagnotto S; Gobbi F; Canta F; Marrone R; Bonora S
    New Microbiol; 2004 Apr; 27(2 Suppl 1):131-4. PubMed ID: 15646076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
    De Clercq E
    Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer antiretroviral agents and how to use them.
    Kim HH; Daar ES
    Curr HIV/AIDS Rep; 2009 May; 6(2):55-62. PubMed ID: 19358775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches.
    De Clercq E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1800-22. PubMed ID: 15183346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
    Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for AIDS.
    Ray S; Fatima Z; Saxena A
    Mini Rev Med Chem; 2010 Feb; 10(2):147-61. PubMed ID: 20408798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reverse transcriptase inhibitors, protease inhibitors].
    Tachikawa N
    Nihon Rinsho; 2012 Apr; 70(4):579-95. PubMed ID: 22568138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond.
    Murphy RL
    AIDS Clin Care; 1999 Jun; 11(6):47-9, 51, 53-4. PubMed ID: 11366882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction to nucleoside and nucleotide analogues.
    Squires KE
    Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.